НОВЫЕ ТЕХНОЛОГИИ В ЛЕЧЕНИИ ЖЕЛЕЗОДЕФИЦИТНОЙ АНЕМИИ В статье представлены сравнительные результаты лечения железодефицитной анемии специализированным продуктом лечебно-профилактического питания на основе комбинации липосомного железа и витамина С в суточной дозе 30 (1 капc.) и 60 мг (2 капc.) и комбинированного препарата двухвалентного железа и витамина С в суточной дозе 100 (1 табл.) и 200 мг (2 табл.) в течение 2-х мес. Получены приблизительно схожие результаты, но достигнутые меньшими дозами препарата липосомного железа при отсутствии побочных эффектов.
O.N. MINUSHKIN, MD, Prof., Central State Medical Academy of RF President Affairs Management HEPATOPROTECTORS IN THE THERAPY OF SOME HEPATIC DISEASESThis article deals with the data on therapy of 130 patients who suffered chronic hepatic diseases (metabolic, viral) and by various reasons received the hepatoprotector and the immune modulator Laenneс. The high effectiveness of patients therapy by steatohepatites (alcoholic and non-alcoholic) was shown. In patients with chronic viral hepatitis B and C, who received antiviral therapy Leannec was used successfully to overcome antiviral therapy resistance, to reduce therapy side effects (high fever, muscular weakness, pancytopenia). Laennec allows overcoming these side effects and anemia therapy resistance in patients who suffered from chronic hepatitis at the hepatic cirrhosis stage.
Aim. Тo evaluate the modern view on the problem of chronic gastritis and the effectiveness of the drug ursodexic acid (UHC) Grinterol in the treatment of patients with chronic antral reflux-gastritis (biliar).
Materials and methods. The work provides modern ideas about chronic gastritis, the issues of etiology and pathogenesis are considered. Contemporary classifications and the attitude of the authors of the work to them are presented. Clinical studies were conducted in 50 patients with chronic antral reflux-gastritis biliary (32 women and 18 men) between the ages of 20 and 80 years (average age 50.3 to 8.0 years). The treatment uses the drug Grinterol in a daily dose of 12.5 mg/kg of body weight for 4 weeks.
Results. Among patients with chronic antral gastritis isolated patients with reflux-gastritis biliary, the pathogenetic factor of which is the damaging property of aggressive bile acids. The main treatment for such patients are drugs UHC (in this study (this study uses Grinterol at a daily dose of 12.5 mg/kg of body weight); the duration of treatment is 4 years. The overall efficiency (according to endomorphological data) was 76%, according to clinical data 100%.
Discussion. Critical consideration of the classifications used and proposed for consideration indicates that the time has come for the adoption of a new classification with the allocation of reflux-gastritis biliary. Treatment of this form of antral gastritis is effective with UDHC drugs.
Conclusion. the selection of a form of antral reflux-gastritis biliar in a separate classification group is scientifically justified. The results suggest that for the treatment of patients with chronic biliary refluxdrugs of choice are drugs UDHC.
This article covers a case of the rare, hereditarily caused disease, "Caroli Syndrome". The publication of this case is important because it shows that rare diseases occur, should be diagnosed and treated at all stages of patient care. It is important to know that this pathology is diagnosed and treated according to the state program — "Rare diseases".
The article presents new definitions of functional disorders of the gastrointestinal tract (Roman criteria IV) and irritable bowel syndrome (from the section of functional disorders of the intestine). Modern pathogenetic links of IBS and changes in intestinal flora as one of the main pathogenetic mechanisms are considered. The use of probiotics in the treatment of IBS is considered and the data of effective treatment of 520 patients (IBS-diarrhea: 120 children and 400 adults) with the new multiprobiotic Bac-Set are presented.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.